Antibody fragment (hinge region)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc7/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc7/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc6/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc6/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc5/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc5/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc4/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc4/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc3/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc3/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc2/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc2/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc1/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc1/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bc0/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bc0/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bbf/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bbf/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bbe/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bbe/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bbd/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bbd/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bbc/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bbc/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bbb/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bbb/5c264e25c405e91300bc0bb9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e5bc405e91300bc0bba/5c264e25c405e91300bc0bb9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e5bc405e91300bc0bba/5c264e25c405e91300bc0bb9.png"}]